PET-MR scan study for head and neck squamous cancer
Part of Cancer clinical trials.
This study uses a combined PET/MR scan to better look at head and neck squamous cell cancer before or during treatment. It may help doctors see where the cancer is and how far it has spread, to support planning for curative radiation treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can read, understand, and sign the consent form for this study.
- You have confirmed squamous cell cancer in the head/neck area (throat, voice box, mouth, or certain sinus/nose areas).
- Your cancer is locally advanced (higher stage) but has not clearly spread to distant sites on scans (M0).
- Your treatment plan is “curative intent” radiation therapy, with or without chemo at the same time.
- Your kidney function is adequate (creatinine clearance at least 60 ml/min).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving lower doses of radiation and chemotherapy is safe and effective for people with certain head and neck cancers. It aims to reduce side effects while keeping the treatment successful.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This study uses a combined PET-MRI scan to measure how much oxygen a head and neck tumor has. It may help doctors understand tumor “oxygen levels,” which can relate to how tumors grow and respond to treatment.
This trial uses special MRI scans to look at your head, neck, and tumor environment before treatment. It aims to find better ways to understand your cancer and guide care.
This study uses repeat MRI scans to look for imaging “markers” that may help doctors better understand head and neck squamous cell cancer. It may be most relevant if you are planning curative surgery and/or (chemo)radiotherapy and can safely undergo MRI more than once.
This study tests whether delaying radiation therapy can help doctors learn more from MRI scans and immune system changes in patients with head and neck cancer. This could lead to better treatment decisions.
Hear when a new Head and Neck Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.